AbstractNatural killer cells are a unique type of lymphocytes with cytotoxic capacity, and play important roles against tumors and infections. Recently, natural killer cells have been increasingly valued in their effects in hepatitis B virus infection. Since hepatitis B virus is not cytopathic, the subsequent antiviral immune responses of the host are responsible for sustaining the liver injury, which may result in cirrhosis and even hepatocellular carcinoma. Many studies have confirmed that natural killer cells participate in anti-hepatitis B virus responses both in the early phase after infection and in the chronic phase via cytolysis, degranulation, and cytokine secretion. However, natural killer cells play dichotomic roles: they exert a...
Hepatitis B virus (HBV) infects over 300 million people worldwide and despite the availability of a ...
Hepatitis B virus (HBV) infects over 300 million people worldwide and despite the availability of a ...
Hepatitis B virus (HBV) infects over 300 million people worldwide and despite the availability of a ...
Hepatitis B is a noncytopathic virus, which exclusively replicates within the liver and affects 350 ...
Natural killer (NK) cells are traditionally regarded as first-line effectors of the innate immune re...
BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are major human hepatotropic pathoge...
There is natural enrichment of NK cells in the human liver and this intrahepatic predominance unders...
BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are major human hepatotropic pathoge...
markdownabstract__Abstract__ Natural killer (NK) cells play a major role in anti-viral immunity a...
Natural killer (NK) cells are traditionally regarded as first-line effectors of the innate immune re...
Natural killer (NK) cells are traditionally regarded as first-line effectors of the innate immune re...
Natural killer (NK) cells are traditionally regarded as first-line effectors of the innate immune re...
Background Hepatitis B virus (HBV) is accounting for over one million deaths annually due to immune-...
Immune modulatory therapies are widely believed to represent potential therapeutic strategies for ch...
Hepatitis B virus (HBV) infects over 300 million people worldwide and despite the availability of a ...
Hepatitis B virus (HBV) infects over 300 million people worldwide and despite the availability of a ...
Hepatitis B virus (HBV) infects over 300 million people worldwide and despite the availability of a ...
Hepatitis B virus (HBV) infects over 300 million people worldwide and despite the availability of a ...
Hepatitis B is a noncytopathic virus, which exclusively replicates within the liver and affects 350 ...
Natural killer (NK) cells are traditionally regarded as first-line effectors of the innate immune re...
BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are major human hepatotropic pathoge...
There is natural enrichment of NK cells in the human liver and this intrahepatic predominance unders...
BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are major human hepatotropic pathoge...
markdownabstract__Abstract__ Natural killer (NK) cells play a major role in anti-viral immunity a...
Natural killer (NK) cells are traditionally regarded as first-line effectors of the innate immune re...
Natural killer (NK) cells are traditionally regarded as first-line effectors of the innate immune re...
Natural killer (NK) cells are traditionally regarded as first-line effectors of the innate immune re...
Background Hepatitis B virus (HBV) is accounting for over one million deaths annually due to immune-...
Immune modulatory therapies are widely believed to represent potential therapeutic strategies for ch...
Hepatitis B virus (HBV) infects over 300 million people worldwide and despite the availability of a ...
Hepatitis B virus (HBV) infects over 300 million people worldwide and despite the availability of a ...
Hepatitis B virus (HBV) infects over 300 million people worldwide and despite the availability of a ...
Hepatitis B virus (HBV) infects over 300 million people worldwide and despite the availability of a ...